nav[aria-label="Primary Navigation"] { padding: 0; & ul { list-style: none; width: 100%; display: flex; flex-direction: row; justify-content: start; align-items: start; gap: 30px; padding: 0; & li { margin: 0; } & ul li { list-style: none; } } }

591593_en-US

liliconcom

2023: A great year to position and sell every product in the JMP Family of Products

In the past it has been said: “sales teams make their numbers with JMP, but go to elite with JMP Pro (and Clinical and Live)”. And also “mid-size deals are the biggest lever sales team have”. Selling JMP Pro, Clinical and Live automatically make for mid-size deals. And while this has been true when company growth goals have been ~10%, with the focus on being a rule of 40 company it’s now become: sales teams must make their numbers by selling an optimal mix of both JMP and JMP premium products (including JMP Pro, JMP Clinical and JMP Live), maximizing the $/hr of sales activities.

Read the full story in Confluence.

Re: 2023: A great year to position and sell every product in the JMP Family of Products

Meeting JMP's corporate growth goal of 15% will require the increased sales efficiency gained by positioning all of JMPs products to our users. Great article!

Comments

There are no comments yet